tiprankstipranks
Advertisement
Advertisement

CVS Group says CMA veterinary ruling manageable and trading on track

Story Highlights
  • CVS Group, a major UK and Australian veterinary provider, says it already meets many regulatory requirements and continues focusing on high-quality clinical services.
  • After the CMA’s final decision on the veterinary market, CVS accepts the revised prescription fee caps, expects trading in line with forecasts, and will work on implementing the remedies.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
CVS Group says CMA veterinary ruling manageable and trading on track

Claim 30% Off TipRanks

CVS Group plc ( (GB:CVSG) ) has issued an announcement.

CVS Group plc, the UK- and Australia-based veterinary services provider, has responded to the Competition and Markets Authority’s final decision in its investigation into the veterinary services market. The company highlighted its scale, with over 475 practices and additional lab and online retail operations, underpinned by a large clinical workforce supporting high-quality animal care.

The CMA’s final decision confirms remedies broadly in line with earlier proposals, including a revised fee cap on prescriptions set at £21 for the first drug and an extra £12.50 for additional drugs prescribed at the same time. CVS said many of the requirements are already met or close to being implemented, such as publishing price lists and joint branding of practices, and the Board expects trading to remain in line with market expectations while it works with the CMA on practical implementation ahead of a Final Order later in 2026.

The most recent analyst rating on (GB:CVSG) stock is a Buy with a £1900.00 price target. To see the full list of analyst forecasts on CVS Group plc stock, see the GB:CVSG Stock Forecast page.

Spark’s Take on CVSG Stock

According to Spark, TipRanks’ AI Analyst, CVSG is a Neutral.

CVS Group plc’s overall stock score is driven by strong financial performance and positive earnings call highlights, including revenue growth and successful acquisitions. However, the high P/E ratio and low dividend yield suggest overvaluation, while technical indicators point to potential overbought conditions. Challenges in the UK market and past cyber incidents also weigh on the score.

To see Spark’s full report on CVSG stock, click here.

More about CVS Group plc

CVS Group plc is a leading veterinary services provider operating in the UK and Australia and listed on the Main Market of the London Stock Exchange. The Group runs more than 475 veterinary practices, including specialist referral hospitals and out-of-hours sites, and also operates diagnostic laboratories and the Animed Direct online retail business, employing around 9,000 staff.

Average Trading Volume: 639,629

Technical Sentiment Signal: Sell

Current Market Cap: £797M

See more data about CVSG stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1